The two rabies vaccines approved in Canada, RabAvert and Imovax Rabies, have both experienced shortages in recent months. RabAvert said a rise in demand is to blame while Imovax has been dealing ...

RabAvert, an approved inactivated virus vaccine, was included as an active comparator arm. All dose levels of RBI-4000 tested, including those as low as 0.1 mcg, elicited de novo protective immune ...

Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and ...

increasing investments in vaccine research, and enhanced healthcare infrastructure in emerging economies. Get Your Free Sample Market Report: What is driving the growth of the global rabavert ...

The Rabavert market size has seen remarkable growth in recent ... to factors such as a rising focus on zoonotic disease prevention, increasing investments in vaccine research, and enhanced healthcare ...